Epilepsy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Healthy volunteers who are fluent in English may be eligible to participate.
- Patients who have been diagnosed with a psychogenic movement disorder (PMD) or psychogenic non-epileptic seizures (PNES) confirmed by a specialist neurologist may be eligible.
- Patients whose treating neurologist does not expect them to need new or changed treatments for 3 to 6 months after the initial screening appointment may be eligible.
Who may not be able to join:
- People who have a significant neurological condition that could affect the study results, as decided by the lead researcher.
- People who have a long-term or worsening medical condition.
- People who have any history of a brain injury or serious head trauma.
- People who currently have a problem with substance misuse or dependence.
- People who have a history of psychosis or another psychiatric condition that could affect the study results.
- People who are pregnant.
- People who have any metal or devices in their head, such as brain stimulators or metal fragments.
- People who have any other implanted metal device in their body, such as a pacemaker, spinal cord stimulator, or vagus nerve stimulator.
- People who have any other magnetic metal material in their body, including some dental prosthetics (confirm with trial site).
- People who are taking certain antidepressants (tricyclic antidepressants), anti-seizure medications, or other brain-affecting drugs listed on a specific safety list (confirm with trial site).
- People who have been diagnosed with an inflammatory or autoimmune condition in the last 6 months.
- Patients with PMD or PNES who also have a diagnosed organic (physically caused) seizure disorder, including febrile or tonic-clonic seizures.
- Patients with PMD or PNES who have another neurological condition such as stroke, fainting, or unexplained loss of consciousness.
- Patients with PMD or PNES who have a serious or unstable physical illness.
- Patients with PMD or PNES who have been diagnosed with dementia, or who score 24 or below on a standard memory and thinking test called the MoCA.
- Patients with PMD or PNES who have experienced repeated visual hallucinations in the past 6 months.
- Patients with PMD or PNES who have a history of significant uncontrollable head movements.
- Patients with PMD or PNES who have any important abnormalities in their basic health measurements such as blood pressure, heart rate, or temperature.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Biyu He, MD, NYU Langone Health
Phone: (212) 263-0228
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Changes in signal intensity measured using of tDCS; Changes in signal intensity measured during EEG recording; Changes in signal intensity measured during MEG
Can't join this trial?
Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.